Trial Details

COMPLETED
Basic Information
Clinical ID c3988
Identifier NCT01225237
Trial Title A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome
Interventions DRUG: Ramosetron|DRUG: Placebo
Participant Information
Sponsor Astellas Pharma Inc
City Hokkaido
Country/Region Japan
Enrollment Criteria
Sex Requirement MALE
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2010-10
Primary Completion Date 2011-08
Completion Date 2011-08